EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)
| 10.49 Delayed Data As of Aug 05 |  -0.02 / -0.19%Today’s Change | 7.00 Today|||52-Week Range 21.50 | -14.30% Year-to-Date |
Institutional investors hold a majority ownership of EYPT through the 75.74% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended June 2019, these large investors purchased a net $609.7 thousand shares.
| Individual stakeholders | 9.49% |
| Other institutional | 47.87% |
| Mutual fund holders | 27.87% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 6/30/2022 | SILVERARC CAPITAL MANAGEMENT LLC Bought 12.0 Thousand shares of EyePoint Pharmaceuticals ... |
| 6/30/2022 | MML INVESTORS SERVICES LLC Bought 54.00 shares of EyePoint Pharmaceuticals ... |
| 6/30/2022 | ELLEVEST, INC. (INVESTMENT MANAG... Sold 11.00 shares of EyePoint Pharmaceuticals ... |
Top 10 Owners of EyePoint Pharmaceuticals Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Franklin Advisers, Inc. | 15.53% | 5,286,404 | 41,603,999 | +364,963 | +7.42% |
| RA Capital Management LP | 9.90% | 3,370,506 | 26,525,882 | 0 | 0.00% |
| Suvretta Capital Management LLC | 8.55% | 2,909,407 | 22,897,033 | +389,707 | +15.47% |
| Adage Capital Management LP | 5.73% | 1,950,000 | 15,346,500 | 0 | 0.00% |
| Janus Henderson Investors US LLC | 4.41% | 1,502,780 | 11,826,879 | -168,403 | -10.08% |
| Citadel Advisors LLC | 4.32% | 1,470,296 | 11,571,230 | +1,083 | +0.07% |
| BlackRock Fund Advisors | 4.03% | 1,371,078 | 10,790,384 | +91,426 | +7.14% |
| The Vanguard Group, Inc. | 3.57% | 1,214,292 | 9,556,478 | +44,887 | +3.84% |
| Point72 Asset Management LP | 3.04% | 1,035,265 | 8,147,536 | +1,032,312 | +34,958.08% |
| Goldman Sachs & Co. LLC (Private ... | 2.43% | 828,274 | 6,518,516 | +252,973 | +43.97% |
Top 10 Mutual Funds Holding EyePoint Pharmaceuticals Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| FTIF SICAV - Biotechnology Discov... | 7.00% | 2,384,482 | 18,765,873 | +124,782 | +5.52% |
| Franklin Small Cap Growth Fund | 5.07% | 1,725,700 | 13,581,259 | 0 | 0.00% |
| Franklin Biotechnology Discovery ... | 3.45% | 1,172,900 | 9,230,723 | 0 | 0.00% |
| Vanguard Total Stock Market Index... | 2.62% | 890,209 | 7,005,945 | +94,700 | +11.90% |
| Janus Henderson Venture Fund | 1.99% | 676,743 | 5,325,967 | 0 | 0.00% |
| iShares Russell 2000 ETF | 1.60% | 543,923 | 4,280,674 | -546 | -0.10% |
| Vanguard Extended Market Index Fu... | 0.89% | 302,989 | 2,384,523 | +2,300 | +0.76% |
| Fidelity Small Cap Index Fund | 0.57% | 194,696 | 1,532,258 | +2,389 | +1.24% |
| iShares Russell 2000 Value ETF | 0.43% | 146,778 | 1,155,143 | -352 | -0.24% |
| Fidelity Extended Market Index Fu... | 0.38% | 127,845 | 1,006,140 | 0 | 0.00% |